Marie-Eve Brien1,2,3, Ines Boufaied1, Nathalie Bernard4, Jean-Claude Forest4,5, Yves Giguere4,5, Sylvie Girard1,2,3. 1. Ste-Justine Hospital Research Center, Montreal, QC, Canada. 2. Department of Obstetrics and Gynecology, Université de Montreal, Montreal, QC, Canada. 3. Department of Microbiology, Infectiology and Immunology, Université de Montreal, Montreal, QC, Canada. 4. Centre de Recherche du CHU de Quebec-Université Laval, Quebec City, QC, Canada. 5. Department of Molecular Biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval, Quebec City, QC, Canada.
Abstract
PROBLEM: Pre-eclampsia (PE), preterm birth (PTB) and intra-uterine growth restriction (IUGR) affect 5%-12% of pregnancies. They have been associated with placental inflammation, although the detection of inflammatory mediators in the maternal circulation is still controversial. Our goal was to determine the inflammatory changes occurring in the second part of pregnancy to identify profiles distinguishing pathological pregnancies from each other. METHOD OF STUDY: We performed a nested case-control study of 200 women randomly selected from a cohort recruited at the CHU de Quebec-Universite Laval, Quebec, Canada. Women with uncomplicated term pregnancy (CTRL); PE (severe or not); PTB or IUGR (N = 50/each) were included. Plasma samples, obtained from the late second trimester and at delivery, were analysed for over 30 selected mediators (including cytokines/alarmins), by multiplex, ELISA or specific assays. Demographic and obstetrical information were obtained for classification. RESULTS: In CTRL, we observed significant differences between 2nd trimester and delivery, with increased levels of inflammatory mediators (ex. MCP-1, IL-6), supporting an inflammatory profile towards term. Increased levels of IL-6, CXCL10 and CRP were observed in PE as compared to CTRL. In PTB, we observed increased CXCL9 in 2nd trimester and decreased progesterone at delivery. In IUGR, increased HMGB1 and IL-1α were observed only in the 2nd trimester. CONCLUSIONS: Our work showed significant inflammatory changes in uncomplicated pregnancies towards delivery, supporting that normal delivery is pro-inflammatory, although not to the same extent as in pathological pregnancies. Inflammatory profiles are specific to each pregnancy complication which may help to understand the contribution of inflammation to the clinical presentation of these conditions.
PROBLEM: Pre-eclampsia (PE), preterm birth (PTB) and intra-uterine growth restriction (IUGR) affect 5%-12% of pregnancies. They have been associated with placental inflammation, although the detection of inflammatory mediators in the maternal circulation is still controversial. Our goal was to determine the inflammatory changes occurring in the second part of pregnancy to identify profiles distinguishing pathological pregnancies from each other. METHOD OF STUDY: We performed a nested case-control study of 200 women randomly selected from a cohort recruited at the CHU de Quebec-Universite Laval, Quebec, Canada. Women with uncomplicated term pregnancy (CTRL); PE (severe or not); PTB or IUGR (N = 50/each) were included. Plasma samples, obtained from the late second trimester and at delivery, were analysed for over 30 selected mediators (including cytokines/alarmins), by multiplex, ELISA or specific assays. Demographic and obstetrical information were obtained for classification. RESULTS: In CTRL, we observed significant differences between 2nd trimester and delivery, with increased levels of inflammatory mediators (ex. MCP-1, IL-6), supporting an inflammatory profile towards term. Increased levels of IL-6, CXCL10 and CRP were observed in PE as compared to CTRL. In PTB, we observed increased CXCL9 in 2nd trimester and decreased progesterone at delivery. In IUGR, increased HMGB1 and IL-1α were observed only in the 2nd trimester. CONCLUSIONS: Our work showed significant inflammatory changes in uncomplicated pregnancies towards delivery, supporting that normal delivery is pro-inflammatory, although not to the same extent as in pathological pregnancies. Inflammatory profiles are specific to each pregnancy complication which may help to understand the contribution of inflammation to the clinical presentation of these conditions.
Authors: Katrin Schmitz; Eva-Maria Turnwald; Tobias Kretschmer; Ruth Janoschek; Inga Bae-Gartz; Kathrin Voßbrecher; Merlin D Kammerer; Angela Köninger; Alexandra Gellhaus; Marion Handwerk; Maria Wohlfarth; Dirk Gründemann; Eva Hucklenbruch-Rother; Jörg Dötsch; Sarah Appel Journal: Nutrients Date: 2022-05-30 Impact factor: 6.706
Authors: Rosa Casas; Sara Castro-Barquero; Francesca Crovetto; Marta Larroya; Ana Maria Ruiz-León; Laura Segalés; Ayako Nakaki; Lina Youssef; Leticia Benitez; Francesc Casanovas-Garriga; Eduard Vieta; Fàtima Crispi; Eduard Gratacós; Ramon Estruch Journal: Nutrients Date: 2022-05-29 Impact factor: 6.706
Authors: Karen Forbes; Rebecca L Jones; Bernadette C Baker; Sylvia Lui; Isabel Lorne; Alexander E P Heazell Journal: Biol Sex Differ Date: 2021-11-17 Impact factor: 5.027
Authors: Bernadette C Baker; Alexander E P Heazell; Colin Sibley; Rachael Wright; Helen Bischof; Frances Beards; Tatiana Guevara; Sylvie Girard; Rebecca L Jones Journal: Sci Rep Date: 2021-03-31 Impact factor: 4.379